FLUVERSE Trademark

Trademark Overview

On Tuesday, August 1, 2023, a trademark application was filed for FLUVERSE with the United States Patent and Trademark Office. The USPTO has given the FLUVERSE trademark a serial number of 98111717. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 29, 2025. This trademark is owned by Seqirus UK Limited. The FLUVERSE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
fluverse

General Information

Serial Number98111717
Word MarkFLUVERSE
Filing DateTuesday, August 1, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB
Party NameSeqirus UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB

Trademark Events

Event DateEvent Description
Friday, August 4, 2023NEW APPLICATION ENTERED
Wednesday, August 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 12, 2024ASSIGNED TO EXAMINER
Friday, October 13, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 13, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2025SOU TEAS EXTENSION RECEIVED
Monday, January 27, 2025SOU EXTENSION 1 FILED
Wednesday, February 5, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 29, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 29, 2025SOU EXTENSION 2 FILED
Tuesday, July 29, 2025SOU EXTENSION 2 GRANTED
Wednesday, July 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2025SOU EXTENSION 1 GRANTED

Related Keywords

fluverse human vaccines